|
Stress Reduction Through Acupuncture
RECRUITINGN/ASponsored by Isabell Xiang Ge
Actively Recruiting
PhaseN/A
SponsorIsabell Xiang Ge
Started2026-07-07
Est. completion2028-07
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07132034
Summary
This randomized controlled trial evaluates whether eight weeks of weekly acupuncture can reduce psychological distress in breast cancer patients who have recently completed primary therapy compared to standard-of-care wait-list control.
Eligibility
Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion criteria: * Patients with localized breast cancer having completed primary therapy (operation +/- chemotherapy +/- radiotherapy) in the last 6 months - Distress Thermometer ≥ 5 - Age ≥ 18 years - Signed informed consent for participation of the trial * Prior cancer is allowed * Prior treatment - including chemotherapy - for a prior malignant tumor (including breast cancer) is allowed * Concomitant participation in an experimental therapeutic drug trial is allowed * Ongoing or planned Anti-her2/neu, immune checkpoint inhibitor, antihormonal and CDK4/6 inhibitor therapy or other adjuvant treatment scheduled for \> 3 months during study period is allowed * Use of other complementary methods (including mistletoe) is allowed. Exclusion criteria: * Patients with language or cognitive deficits (including impaired consciousness) that are incompatible with the participation in the study * Severe physical or psychiatric comorbidity that prevents a patient from participating in the study * Patients incapable of giving consent * Pregnancy
Conditions4
AcupunctureBreast CancerCancerSurvivorship
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorIsabell Xiang Ge
Started2026-07-07
Est. completion2028-07
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07132034